These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18673165)

  • 1. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders.
    Rivara S; Mor M; Bedini A; Spadoni G; Tarzia G
    Curr Top Med Chem; 2008; 8(11):954-68. PubMed ID: 18673165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin receptor agonists: new options for insomnia and depression treatment.
    Spadoni G; Bedini A; Rivara S; Mor M
    CNS Neurosci Ther; 2011 Dec; 17(6):733-41. PubMed ID: 21554566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin agonists and insomnia.
    Ferguson SA; Rajaratnam SM; Dawson D
    Expert Rev Neurother; 2010 Feb; 10(2):305-18. PubMed ID: 20136385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
    Laudon M; Frydman-Marom A
    Int J Mol Sci; 2014 Sep; 15(9):15924-50. PubMed ID: 25207602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin and its analogs in insomnia and depression.
    Cardinali DP; Srinivasan V; Brzezinski A; Brown GM
    J Pineal Res; 2012 May; 52(4):365-75. PubMed ID: 21951153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole-based melatonin analogues: Synthetic approaches and biological activity.
    Wang SY; Shi XC; Laborda P
    Eur J Med Chem; 2020 Jan; 185():111847. PubMed ID: 31727472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating insomnia: Current and investigational pharmacological approaches.
    Ebert B; Wafford KA; Deacon S
    Pharmacol Ther; 2006 Dec; 112(3):612-29. PubMed ID: 16876255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
    Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
    J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP; Mulchahey JJ; Scharf MB; Mayleben DW; Rosenberg R; Lankford A
    J Clin Psychiatry; 2005 Mar; 66(3):384-90. PubMed ID: 15766306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP; McLin DE; Dressman MA; Neubauer DN
    Pharmacotherapy; 2016 Sep; 36(9):1028-41. PubMed ID: 27500861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V; Shankar PK
    J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in melatonin receptor ligands.
    Zlotos DP
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):229-47. PubMed ID: 15952241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.